Mayne Pharma LLC
USPTO PatentsView assignee record - 7 granted patents across 9 technology areas, recorded in grant years 2020–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61K (Preparations FOR Medical, Dental OR Toiletry Purposes).
The verdict
According to USPTO PatentsView, Mayne ranks #36,407 of 49,997 tracked US assignees by granted-patent volume, with 7 patents across 9 technology areas.
- #36,407
- of 49,997 US assignees by volume
- 20th percentile
- by Innovation Score (26.4/100)
- 14.3
- avg claims per patent
USPTO PatentsView assignee plate
Corpus R36407 · US Corporation #36,407 · 7 grants
GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-RICH · TYPE-USCORP · SPAN-YRS · BOOK-RICH
- GRANTS-MICRO 7 grants
- MID-PACK #36,407/49,997
- PHOTO-FINISH Maxi-Lift
- CPC-NARROW A61K · 9 areas
- INNOV-THIN 26.4/100
- CLAIMS-RICH 14.3 claims/avg
- TYPE-USCORP US Corporation
- SPAN-YRS 2020–2025 · 6y
- BOOK-RICH 9/10 fields
Nearest grant-volume peer: Maxi-Lift, Inc. (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
How Mayne’s 26.4 Innovation Score adds up
The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.
Innovation-score neighbourhood around Mayne
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
- Qualcomm Incorporated · highest
Qualcomm Incorporated · highest
85 score
- Mayne Pharma · this assignee 26
Mayne Pharma · this assignee
26 score
- 3D Lighting… · lowest 7
3D Lighting… · lowest
7 score
What this shows Mayne's Innovation Score is 26.4/100 (20th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.
Does more volume mean deeper claims for Mayne?
Each dot is one of Mayne’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Mayne’s own 14.3 claims/patent is ABOVE the 11.1 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.
Where Mayne's grants concentrate
Mayne Pharma LLC is a focused PatentsView assignee: 9 CPC subclasses with 100% of grants classified under A61K (Preparations FOR Medical, Dental OR Toiletry Purposes). Peak complete grant year is 2020 (3 grants) versus a trough of 1 in 2021. By volume, Mayne sits between Maxi-Lift, Inc. and MedInTech Inc..
Who files at Mayne's volume?
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
- Maxi-lift
Maxi-Lift, Inc.
7 patents
- Maxion Wheels Hol…
Maxion Wheels Holding GmbH
7 patents
- Maxx Media Group
Maxx Media Group, LLC
7 patents
- Mayborn (UK)
Mayborn (UK) Limited
7 patents
- Mchale Engineering
McHale Engineering
7 patents
- Mcnaughton Incorp…
McNaughton Incorporated
7 patents
- Med-life Discover…
Med-Life Discoveries LP
7 patents
- Medintech
MedInTech Inc.
7 patents
- Mayne Pharma ◀
Mayne Pharma LLC
7 patents
What this shows Mayne holds 7 patents at rank #36,477, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
Companies ranked near Mayne
By rank, the assignees closest to #36,477 in granted patent volume.
- Maxi-Lift, Inc. #36,473 · 7 patents
- Maxion Wheels Holding GmbH #36,474 · 7 patents
- Maxx Media Group, LLC #36,475 · 7 patents
- Mayborn (UK) Limited #36,476 · 7 patents
- McHale Engineering #36,478 · 7 patents
- McNaughton Incorporated #36,479 · 7 patents
- Med-Life Discoveries LP #36,480 · 7 patents
- MedInTech Inc. #36,481 · 7 patents
Leaders in A61K (Preparations FOR Medical)
Other assignees with the most granted patents in Mayne's primary technology class.
- The Regents of the University of California 1,779 in class
- L'Oreal 1,250 in class
- Novartis AG 988 in class
- The Procter & Gamble Company 985 in class
- The Board of Regents of the University of Texas System 950 in class
- The United States of America, as represented by the Secretary, Department of Health and Human Services 813 in class
- The Trustees of the University of Pennsylvania 768 in class
- Merck Sharp & Dohme LLC 760 in class
Mayne's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
26 20th percentile higher than 20% of 49,997 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Grants by year
Teal-shaded recent years (2020–present) versus the 2020–2019 baseline. Full figures in the table below.
View data table
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2020 | 3 | 42.9% |
| 2021 | 1 | 14.3% |
| 2025partial year | 3 | 42.9% |
Which technologies does Mayne Pharma LLC patent most?
Top 9 of 9 technology areas
Data Source
USPTO PatentsView, US granted patents 2015–2025
What to do with this data
Mayne Pharma LLC's patent record in context - here's where to go next.
- Mayne Pharma LLC's lead technology class is A61K (Preparations FOR Medical, Dental OR Toiletry Purposes), 100% of its portfolio - see every assignee active in that class. Explore A61K
- Ranked #36,407 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
- Compare Mayne Pharma LLC against Maxi-Lift, Inc., an assignee filing at a similar volume. Compare portfolios
- Innovation Score of 26.4/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated
Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.